Curis Announces Presentations of CUDC-907 and Erivedge(R) Clinical Data at 2015 ASCO Annual Meeting
May 20, 2015 at 07:01 AM EDT
Curis, Inc. (Nasdaq: CRIS), a biotechnology company focused on the development and commercialization of innovative drug candidates for ...